Rousselot announces its presence at CPHI Paris, 5-7 October 2010, Stand 6M14

Paris La Défense, July 21st 2010 – Rousselot, the leading producer of gelatine and hydrolyzed collagen worldwide, will participate in the next CPHI tradeshow which will take place from 5 to 7 October at Paris-Villepinte Exhibition Center. The Group will be presenting a complete and renewed range of pharmaceutical gelatines as well as Peptan ™ hydrolyzed collagens.

Quality and diversity of Rousselot® pharmaceutical Gelatines
Rousselot gelatines play an important role in the pharmaceutical industry and helps improving patient care quality. It is used in almost one third of all hard and soft capsules manufactured worldwide; it is also widely used for the manufacturing of tablets and enters the composition of plasma substitute or ostomy devices. Careful selection of raw materials, high standards of hygiene and repeated controls at all manufacturing process stages guarantee the constant quality of all Rousselot® pharmaceutical gelatines worldwide.

First presentation of Peptan ™ Hydrolyzed Collagen to the European pharmaceutical industry
During the CPHI, for the first time, Rousselot will be presenting its Peptan offer to the pharmaceutical market. A bioactive ingredient, Peptan™ hydrolyzed collagen contributes to bone, joint and skin health. These health and anti aging benefits have been clearly reported in scientific studies, which will be available for consultation at the Rousselot stand.

Rousselot looks forward to welcoming its visitors to stand 6M14 located on Exhibition Center Hall 6.